Crispr Stem & Therapeutics (CST) Overview
Crispr Stem & Therapeutics (CST) is developing a patented cardio-protective CRISPR-based stem cell protocol to restrict the damage to the heart following acute heart attack and chronic heart failure. The company's technology will use CRISPR to genetically modify the patient's own stem cells, which are then treated by Crispr Stem & Therapeutics protocol and implanted in the patient with acute ischemic heart disease. The company's protocol was tested in several proof-of-concept experiments both in vitro and in vivo in animal models and showed dramatically decreased damage to the heart. The protocol aims to increase patients' life expectancy and quality of life, enable quick recovery, shorten hospitalization, and eliminate the risk of rejection. The company received recognition from the Israeli Innovation Authority (Tnufa funding) and European Commission with two Seals of Excellence.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | $100K |
| Last funding | $100K |
| Stage | Pre-Funding |
| Rounds | 1 |
| Investors | 0 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | www.crisprstemtherapeutics.com/ |
Locations
Petah Tikva, Israel
Photos & Videos
No files yet
Crispr Stem & Therapeutics (CST) Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentTarget Customer
Healthcare & Life SciencesHealthcareProvidersLife SciencesBiotechnologyCore Technology
BiologicalsCellsGenesTags (8)
ischemiatherapeuticscardiovascularheart-failurecell-therapymedical-technologiesstem-cellstissue-regenerationCrispr Stem & Therapeutics (CST) Financials
Non-Equity Funding
Crispr Stem & Therapeutics (CST) Lifecycle
All Events
Crispr Stem & Therapeutics (CST) News
0 articlesNo news articles.
Crispr Stem & Therapeutics (CST) Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 1 |
| Team members | 2 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 11 classification IDs that could be used for matching.
Crispr Stem & Therapeutics (CST) Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 87/100 |
| Missing | video or image, funding rounds, news, markets, not claimed |
| BI Verification | Yotam Maman |
| Registrar ID | 515840445 |
| Creator | Yotam Maman |
| Creator email | yotamm1988@gmail.com |
| Last updater | Yotam Maman |
| Updater email | yotamm1988@gmail.com |
| Last update | 2021-10-17T00:00:00.000Z |
| Created | 2019-12-05T00:00:00.000Z |
| Claimed | Yes |